Home/Filings/4/0001209191-23-001886
4//SEC Filing

Winter Charles M. 4

Accession 0001209191-23-001886

CIK 0001817713other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:36 PM ET

Size

5.5 KB

Accession

0001209191-23-001886

Insider Transaction Report

Form 4
Period: 2023-01-03
Winter Charles M.
Chief Technical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-03+100,000100,000 total
    Exercise: $14.02Exp: 2033-01-02Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on January 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period.

Issuer

Janux Therapeutics, Inc.

CIK 0001817713

Entity typeother

Related Parties

1
  • filerCIK 0001960264

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:36 PM ET
Size
5.5 KB